Jennifer Epler
Founder and Principal Biomedical Writer
Hello!
In my first career, I was a scientist at the bench in both academia and pharma for many years. My research spanned cell biology, T-cell immunotherapy, translational oncology, and small-molecule drug development. I loved diving into the medical literature, attending conferences, and producing numerous abstracts, manuscripts, posters, and slide decks. In my experience, data presentation is always enhanced by clear, concise writing.
Communication is my favorite part of advancing biomedical science.
In 2021, I completed a second master's degree in Science Writing. Since then, I have written many types of science and medical content, including promotional materials for biotech products, educational materials for pharma salespeople, medical news, plain-language summaries, regulatory documents, and conference reports.
I founded Concise Biomedical Writing in 2024. My main focus now is continuing medical education (CME) and continuing professional development (CPD). However, I also love writing about the latest advancements in medicine to a variety of audiences through clinical trial summaries and conference reports. What kind of project can we create together?
More about Jennifer
Professional Affiliations
Alliance for Continuing Education in the Health Professions (ACEHP), active member since 2024
American Medical Writers Association (AMWA), active member since 2023, and current Chair of the Communications Committee
Education
MA in Science Writing, Johns Hopkins University (2021)
MS in Microbiology, Immunology, and Cancer Biology (MICaB program), University of Minnesota (2000)
BS in Biochemistry, University of Washington (1996)
I consider myself a lifelong learner and love gaining new expertise! A variety of recent projects have sparked my curiosity and made writing a joy. Some of these topics include:
Expanding applications for CAR T cell therapy: oncology and autoimmune disease
Practical considerations for advanced practice providers (APPs) administering tumor-infiltrating lymphocyte (TILs) therapy
Use of lifestyle and pharmaceutical interventions for metabolic dysfunction-associated steatohepatitis (MASH)
Management of hyperglycemia in patients receiving phosphatidylinositol 3-kinase inhibitor therapy
Mastery of clinical trial results and Prescribing Information documents by pharma sales teams
Use of AI to diagnose and track age-related macular degeneration (AMD)
Emerging antibody-drug complex (ADC) therapies for breast cancer and for bladder cancer
Optimized dosing for gout treatments in patients with chronic kidney disease (CKD)
These research projects grew into needs assessments, patient cases, slide decks, conference reports, clinical trial summaries, plain-language explainers, study guides, quizzes, and more. Although client confidentiality agreements prevent me from showing some finished products, others are available to you in my portfolio.